ACURATE neo2 TAVI achieves high success in severe bicuspid aortic stenosis, demonstrating strong 30-day safety and efficacy.

Executives expect a new label indication and a hoped-for easing of hospital capacity constraints to accelerate sales this ...

Coronary events after TAVR are rare but impact survival. PCI improves outcomes, particularly in balloon-expandable valve ...

HYDERABAD: Doctors at Citizens Hospital successfully treated a 72-year-old patient with severe aortic valve stenosis and ...

Women are often underdiagnosed and undertreated when it comes to heart disease, particularly conditions like aortic stenosis.

Aortic stenosis, affecting nine million people globally, is often unnoticed as symptoms are mistaken for aging. This heart condition, common in elderly, restricts blood flow due to valve narrowing, ...

Edwards Lifesciences shares rise as analyst upgrades stock, citing TAVR growth, margin expansion, and strategic business changes for 2025.

Background Aortic stenosis is a degenerative condition with high mortality in its severe stages and no preventive treatment.

The Heart and Vascular center at Portneuf Medical Center recently marked its 400th transaortic valve replacement procedure.

Big picture: Thanks to investments in landmark clinical trials, Edwards is poised to significantly enlarge the TAVR patient pool by expanding therapy to the other half of severe aortic stenosis ...

AISAP, a medical technology company developing AI-powered Point-of-Care Assisted Diagnosis (POCAD™) solutions to transform ...